Physician profile
John T Decker
NPI 1578512257
$1,342.12
in general payments reported to CMS, 2019-2025
20 companies · $16.71 in 2025
The $16.71 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.13 · 2020: $34.06 · 2021: $16.35 · 2022: $205 · 2023: $537 · 2024: $509 · 2025: $16.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $942 · Education: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.83 |
| Education | $120.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $233.18 | 2023-2024 | Myfembree |
| Astellas Pharma US INC | $175.02 | 2023-2024 | Veozah, Myrbetriq |
| Organon LLC | $137.42 | 2022-2024 | Nexplanon |
| Pacira Pharmaceuticals Incorporated | $101.30 | 2023-2024 | Exparel, Iovera |
| Myovant Sciences INC. | $90.75 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $86.72 | 2023-2024 | |
| Hologic Sales and Service, LLC | $74.68 | 2019-2024 | Aptima |
| Merck Sharp & Dohme LLC | $62.67 | 2022-2024 | Gardasil 9, Gardasil |
| Atricure, INC. | $57.30 | 2024-2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System, Atriclip Laa Exclusion System |
| Biogen, INC. | $52.01 | 2024 | Zurzuvae |
| Abbvie INC. | $46.73 | 2022-2023 | Lo Loestrin Fe, Liletta |
| Pfizer INC. | $36.70 | 2023-2024 | |
| Viiv Healthcare Company | $34.06 | 2020 | |
| Scynexis, INC. | $32.85 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.01 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $26.70 | 2024 | |
| Ethicon US, LLC | $25.14 | 2023 | Dermabond Prineo, Ethicon |
| Optumhealth Care Solutions, LLC | $14.41 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Exeltis, USA INC. | $14.04 | 2024 | Slynd |
| Allergan, INC. | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Decker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.